James L. Tyree, Director at Innoviva, holds 9.71K shares in Genelux Corp. (Ticker: GNLX), holds 188.25K shares in Assertio Therapeutics (Ticker: ASRT), holds 0.00 shares in ChemoCentryx (Ticker: CCXI).
What is the percentage of profitable transactions made by James L. Tyree?
The percentage of profitable transactions made by James L. Tyree is 50%.
What is the average return per transaction made by James L. Tyree?
The average return per transaction made by James L. Tyree is 38.00%.
What stocks does James L. Tyree hold?
James L. Tyree holds: INVA, ASRT, GNLX, CCXI, ABT stocks.
What was James L. Tyree’s latest transaction?
James L. Tyree latest transaction was an Uninformative Buy of ―.
What was James L. Tyree's most profitable transaction?
James L. Tyree’s most profitable transaction was an Informative Sell of GNLX stock on December 14, 2023. The return on the trade was 86.80%.
What is James L. Tyree's role in Innoviva?
James L. Tyree's role in Innoviva is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.